The Advanced Medical Technology Association (AdvaMed) said FDA's proposed expedited program for premarket approval medical devices is too narrowly tailored and should be expanded to include devices cleared through the 510(k) pathway. Patient and consumer advocates, however, criticized the program, saying device approval standards are already too low. The agency in April released a guidance document outlining an expedited access premarket approval program for medical devices that are intended to treat or diagnose a life-threatening or irreversibly debilitating disease or...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.